Mammoth Biosciences

Brisbane, CA · founded 2017

Mammoth Biosciences is a CRISPR company co-founded in 2017 by Nobel laureate Jennifer Doudna together with Trevor Martin, Janice Chen and Lucas Harrington, built around 'ultra-small' Cas enzymes such as CasPhi and Cas14 that are small enough to deliver through viral vectors. It first pursued CRISPR-based diagnostics (its DETECTR platform was used for COVID-19 testing) and in 2023 announced a refocus onto CRISPR-based therapies, with pharma partnerships including Vertex and Bayer. Honest caveat: at the time of this collection the company's public website and job board were unreachable or parked and no current benefits information could be sourced, so its present status and offerings should be treated as uncertain.

we do not know enough about Mammoth Biosciences yet

Nothing on this page is documented yet. Everything we publish has to be something a stranger can click through and check, so we would rather show a thin page than a confident guess.

• Have you worked here? Tell us what the offer actually included. We mark what people tell us as testimony, keep your name out of it, and never publish it as fact. tell us what you know
• Do you work at Mammoth Biosciences? Claim this page and send the links you already publish, and we will document them properly, dated and sourced. claim this company

Every claim above is sourced and dated. See sources on the full page.

Work at Mammoth Biosciences and something here is wrong or out of date? Tell us at hello@perks.global and we will check it.